WPA
MEDP icon

West Paces Advisors’s Medpace MEDP Stock Holding History

West Paces Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38
Closed -$11.6K – 644
2023
Q4 		$11.6K Hold
38
– – ﹤0.01% 348
2023
Q3 		$9.2K Hold
38
– – ﹤0.01% 352
2023
Q2 		$9.13K Hold
38
– – ﹤0.01% 376
2023
Q1 		$7.15K Hold
38
– – ﹤0.01% 393
2022
Q4 		$8.07K Hold
38
– – ﹤0.01% 372
2022
Q3 		$5.97K Hold
38
– – ﹤0.01% 376
2022
Q2 		$5.69K Hold
38
– – ﹤0.01% 397
2022
Q1 		$6.22K Hold
38
– – ﹤0.01% 396
2021
Q4 		$8.27K Buy
38
+4
+12% +$838 ﹤0.01% 394
2021
Q3 		$6.44K Hold
34
– – ﹤0.01% 395
2021
Q2 		$6K Buy
+34
New +$5.87K ﹤0.01% 411

Other funds holding MEDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

West Paces Advisors's MEDP Position: Q1 2024 in Review

West Paces Advisors sold out of Medpace (MEDP) in Q1 2024, closing a stake of 38 shares — an estimated $11.6K sold.

West Paces Advisors first reported a position in MEDP in Q2 2021 and held it in 11 quarters. The position peaked at $11.6K in Q4 2023. 597 funds tracked by Wall St. Rank hold MEDP as of Q1 2024.

  • West Paces Advisors reported no remaining Medpace position as of Q1 2024 after selling out during the quarter.
  • West Paces Advisors sold 38 Medpace shares in Q1 2024, an estimated $11.6K.
  • West Paces Advisors first reported a position in Medpace in Q2 2021 and held it in 11 quarters.
  • West Paces Advisors's Medpace position peaked at $11.6K in Q4 2023.
  • 597 funds tracked by Wall St. Rank held Medpace as of Q1 2024.

Based on West Paces Advisors's 13F filing for Q1 2024, filed 15 Apr 2024.